Oral contraception in Denmark 1998-2010

Acta Obstetricia et Gynecologica Scandinavica

Volumn 91, Issue 7, 2012, Pages 810-815

  Wilson, Nadia M ^a   Laursen, Maja ^b   Lidegaard, Øjvind ^a  

^a Rigshospitalet   (Denmark)

^b DANISH MEDICINES AGENCY   (Denmark)

Author keywords

Combined oral contraceptives; Estrogen dose; Oral contraceptives; Progestins; Progestogens

Indexed keywords

DESOGESTREL; DROSPIRENONE; ESTROGEN; GESTAGEN; GESTODENE; LEVONORGESTREL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DENMARK; FEMALE; HUMAN; ORAL CONTRACEPTION; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; CONTRACEPTIVES, ORAL; DENMARK; FEMALE; HUMANS; MIDDLE AGED; PRODUCT SURVEILLANCE, POSTMARKETING; REGISTRIES;

EID: 84862863805     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2012.01416.x     Document Type: Article

References (9)

1. Skjeldestad FE. Prevensjonsbruken i Norge i 2005. Tidsskr Nor Lægeforen. 2007;21:2803-5.
2. Skouby SO. Contraceptive use and behavior in the 21st century: a comprehensive study across five European countries. Eur J Contracept Reprod Health Care. 2004;9:57-68.
3. Li HR, Anderson R. Recent advances in hormonal contraception. F1000 Med Rep. 2010;2:1-3.
4. Lidegaard Ø, Schiødt AV, Poulsen EF. P-piller og trombose. Ugeskr Laeger. 2001;163:4549-53.
5. Sitruk-Ware R, Nath A. The use of newer progestogens for contraception. Contraception. 2010;82:410-7.
6. Vlieg AH, Helmerhorst FM, Vandenbroucke JP, Doggen CJM, Rosendaal FR. The venous thrombotic risk of oral contraceptives, effects of estrogen dose and progestogen type: results of the MEGA case-control study. Br Med J. 2009;339:b2921.
7. Lidegaard Ø, Nielsen LH, Skovlund CW, Skjeldestad FE, Løkkegaard E. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and estrogen doses: Danish cohort study 2001-9. Br Med J. 2011;343:d6423.
8. United Nations, Department of Economic and Social Affairs, Population Division (2011).World Contraceptive Use 2010 (POP/DB/CP/Rev2010).
9. Food and Drug Adminidsration, Office of surveillance and epidemiology. Combined hormonal contraceptives (CHCs) and the risk of cardiovascular disease endpoints. FDA 2011: http://www.fda.gov/downloads/Drugs/DrugSafety/UCM277384. pdf.